Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depression
Aust N Z J Psychiatry. 2023 Oct 13:48674231203898. doi: 10.1177/00048674231203898. Online ahead of print.ABSTRACTIn this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for non-commercial entities to fill this gap. As a result, the evaluation of generic ketamine was delayed, piecemeal, uncoordinated, an...
Source: The Australian and New Zealand Journal of Psychiatry - October 13, 2023 Category: Psychiatry Authors: Anthony Rodgers Dilara Bahceci Christopher G Davey Mary Lou Chatterton Nick Glozier Malcolm Hopwood Colleen Loo Source Type: research

Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder
CONCLUSION: Pharmacotherapy added to psychosocial support was cost-effective from both healthcare and societal perspectives, emphasising an increased role for pharmacotherapy to reduce the burden of alcohol use disorders.PMID:37822267 | DOI:10.1177/00048674231201541 (Source: The Australian and New Zealand Journal of Psychiatry)
Source: The Australian and New Zealand Journal of Psychiatry - October 12, 2023 Category: Psychiatry Authors: Benjamin Higginbotham Joahna Kevin Perez Eva Louie Paul S Haber Dan Lubman Shalini Arunogiri Mary Lou Chatterton Kirsten C Morley Source Type: research

Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder
CONCLUSION: Pharmacotherapy added to psychosocial support was cost-effective from both healthcare and societal perspectives, emphasising an increased role for pharmacotherapy to reduce the burden of alcohol use disorders.PMID:37822267 | DOI:10.1177/00048674231201541 (Source: The Australian and New Zealand Journal of Psychiatry)
Source: The Australian and New Zealand Journal of Psychiatry - October 12, 2023 Category: Psychiatry Authors: Benjamin Higginbotham Joahna Kevin Perez Eva Louie Paul S Haber Dan Lubman Shalini Arunogiri Mary Lou Chatterton Kirsten C Morley Source Type: research

Research Letter: Flooding, displacement, peritraumatic experience and disaster-related PTSD in northern New South Wales - The critical need for quality data to plan mental health support
Aust N Z J Psychiatry. 2023 Oct 4:48674231203901. doi: 10.1177/00048674231203901. Online ahead of print.NO ABSTRACTPMID:37791723 | DOI:10.1177/00048674231203901 (Source: The Australian and New Zealand Journal of Psychiatry)
Source: The Australian and New Zealand Journal of Psychiatry - October 4, 2023 Category: Psychiatry Authors: Jo Longman Kazi Rahman Veronica Matthews James Bennett-Levy Source Type: research

Research Letter: Flooding, displacement, peritraumatic experience and disaster-related PTSD in northern New South Wales - The critical need for quality data to plan mental health support
Aust N Z J Psychiatry. 2023 Oct 4:48674231203901. doi: 10.1177/00048674231203901. Online ahead of print.NO ABSTRACTPMID:37791723 | DOI:10.1177/00048674231203901 (Source: The Australian and New Zealand Journal of Psychiatry)
Source: The Australian and New Zealand Journal of Psychiatry - October 4, 2023 Category: Psychiatry Authors: Jo Longman Kazi Rahman Veronica Matthews James Bennett-Levy Source Type: research